⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7870176 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL11574179 | 0.97 | — | — | |
| SCHEMBL3101060 | 0.77 | — | — | |
| SCHEMBL30707879 | 0.77 | — | — | |
| SCHEMBL1146614 | 0.77 | — | — | |
| SCHEMBL23777967 | 0.76 | SLC1A3 (0.35) | — | |
| SCHEMBL28472462 | 0.75 | — | — | |
| SCHEMBL6517894 | 0.75 | — | — | |
| SCHEMBL8022123 | 0.73 | — | — | |
| SCHEMBL17056093 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724418-A1 | TRICINE AND CITRIC ACID-BASED CATIONIC LIPIDS | Sanofi (FR) | 2026-04-15 | — | — | EP | disclosed |
| US-20260022143-A1 | Cyclic Peptide Inhibitors of IL-23 | JANSSEN PHARMACEUTICA NV (BE) | 2026-01-22 | — | — | US | disclosed |
| EP-4638415-A1 | BIS-ESTER AND AMIDE CATIONIC LIPIDS | Sanofi Pasteur Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| WO-2025003755-A1 | HELPER LIPIDS FOR NUCLEIC ACID DELIVERY | SANOFI (FR) | 2025-01-02 | — | — | WO | disclosed |
| WO-2025003759-A1 | DIANHYDROHEXITOL BASED IONIZABLE LIPIDS FOR NUCLEIC ACID DELIVERY | SANOFI (FR) | 2025-01-02 | — | — | WO | disclosed |
| CN-118922409-A | Asymmetric piperazine-based cationic lipids | 翻译生物公司 | 2024-11-08 | — | — | CN | disclosed |
| WO-2024133853-A1 | BIS-ESTER AND AMIDE CATIONIC LIPIDS | SANOFI (FR) | 2024-06-27 | — | — | WO | disclosed |
| EP-4362920-A1 | COMPOSITIONS FOR DELIVERY OF MRNA | Translate Bio, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-4326338-A1 | IMPROVED COMPOSITIONS FOR DELIVERY OF MRNA | Translate Bio, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4323346-A1 | GOOD\"BUFFER-BASED CATIONIC LIPIDS | Translate Bio, Inc. (US) | 2024-02-21 | — | — | EP | disclosed |
| WO-2003092581-A9 | CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS | HK PHARMACEUTICALS INC (US) | 2004-02-19 | — | — | WO | disclosed |
| EP-1019528-B1 | METHOD FOR ASSAYING PROTEOLYTIC ENZYMES USING FLUORESCENCE-QUENCHED SUBSTRATES | TNO (NL) | 2003-10-29 | — | — | EP | disclosed |
| US-6127139-A | INCUBATING SAMPLE WITH AN IMMOBILIZED SUBSTRATE, OPTIONALLY SEPARATING THE LIQUID FROM THE CARRIER, IRRADIATING CARRIER AND MEASURING FLUORESCENCE | NEDERLANDS ORGANISATLE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK (TNO) (NL) | 2000-10-03 | — | — | US | disclosed |
| EP-1019528-A1 | METHOD FOR ASSAYING PROTEOLYTIC ENZYMES USING FLUORESCENCE-QUENCHED SUBSTRATES | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2000-07-19 | — | — | EP | disclosed |
| WO-1997025437-A1 | METHOD FOR ASSAYING PROTEOLYTIC ENZYMES USING FLUORESCENCE-QUENCHED SUBSTRATES | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 1997-07-17 | — | — | WO | disclosed |
| US-4372974-A | Anticonvulsive compositions and method of treating convulsive disorders | NEW YORK UNIVERSITY (US) | 1983-02-08 | — | — | US | disclosed |
| US-4322440-A | Anticonvulsive compositions and method of treating convulsive disorders | NEW YORK UNIVERSITY (US) | 1982-03-30 | — | — | US | disclosed |
| US-4169834-A | RIFAMYCIN DERIVATIVES | GRUPPO LEPETIT S.P.A. (IT) | 1979-10-02 | — | — | US | disclosed |
| US-4147701-A | BACTERICIDES, 1-CARBOXYMETHYLTHIOETHYLTETRAZOLE-5-THIOL | SMITHKLINE CORPORATION (US) | 1979-04-03 | — | — | US | disclosed |
| US-4057631-A | CEPHALOSPORINS, BACTERICIDE | SMITHKLINE CORPORATION (US) | 1977-11-08 | — | — | US | disclosed |